CBG – cannabigerol, what do we know about it?
CBG, also known as cannabigerol, is another of over 120 cannabinoids identified in the cannabis plant.
It has no psychoactive properties and its potential for therapeutic applications is currently being researched.
This is a very interesting molecule because it is the precursor to the most popular THC and CBD. It is created as one of the first molecules in the form of CBGA and occurs in the highest concentrations during the development of hemp plants. The plant's own enzymes, over time, act on CBGA and break it down into THCA, CBDA and CBCA. However, if we precipitate the acid from CBGA (through the aforementioned exposure to light / heat / steam), we will get CBG.
Most cannabis varieties contain very low levels of CBG – below 1%. This does not mean that this cannabinoid is not valuable, quite the opposite. It is able to increase dopamine levels, which improves sleep, mood and appetite. It also inhibits GABA neurotransmission in the brain, which reduces overall muscle tension and tension. It inhibits serotonin receptors and thus reduces symptoms of anxiety and depression. In addition, CBG is currently recognized as particularly effective in the following diseases:
Cancer – according to recent studies, it can be used as an anti-cancer agent because it has the potential to block receptors responsible for the growth of cancer cells. Scientists report inhibition of colon cancer cell growth in mice given CBG, so it is a new alternative in the treatment of cancer patients. It is also effective as a cytotoxic agent acting on epithelial cancer and breast cancer in humans.
Glaucoma – CBG has proven to be incredibly effective in lowering the intraocular pressure associated with glaucoma. Scientists attribute this phenomenon to the fact that endocannabinoid receptors are highly concentrated in the structures of the eye.
MRSA – Studies conducted in Europe revealed the antibiotic properties of CBG when applied topically to patients suffering from MRSA infection. (MRSA is a strain of Staphylococcus aureus that is resistant to methicillin, which is almost all antibiotics)
In addition to the above diseases, CBG shows potential as an anti-inflammatory agent for nonspecific bowel disease, slows down the degeneration of nerve cells, stimulates appetite, and improves and regulates bladder function.
